Rituximab Uses
Links shared publicly online about this topic
Medical News: Rituximab Useful in Refractory Lupus - in Rheumatology, Lupus from MedPage Today
medpagetoday.com — “Rituximab appears to be both effective and safe for patients with refractory systemic lupus erythematosus an open, observational study based on physician-reported outcomes suggested.” View full resource at medpagetoday.com
Most Recently Shared on August 6, 2010 at 2:41 pm By:
Rituximab May Be Useful in Refractory Lupus (CME/CE) (MedPage Today) -- Rituximab appears to be both effective and safe.. http://dld.bz/qMK7
IngentaConnect Rituximab: A Review of its Use in Chronic Lymphocytic Leukaemia, ...
ingentaconnect.com — “IngentaConnect Rituximab: A Review of its Use in Chronic Lymphocytic Leukaemia, ...” View full resource at ingentaconnect.com
Most Recently Shared on July 10, 2010 at 10:44 am By:
Drugs and Devices OW OW Health
Rituximab: A Review of its Use in Chronic Lymphocytic Leukaemia, Low-Grade or Follicular Lymphoma and Diffuse Larg... http://bit.ly/bYXmlb
Rituximab Deemed Useful for Certain Lupus Subgroups : Skin & Allergy News
skinandallergynews.com — “Skin & Allergy News Digital Network is the online destination and multimedia properties of Skin & Allergy News, the independent news publication for the dermatology community. Our breaking news covers all areas of medical dermatology, dermatologic surgery, and aesthetic dermatology. We also provide the news by specialty interest: acne and rosacea, atopic dermatitis and eczema, cutaneous oncology, hair and nails, infectious diseases, pediatric dermatology, psoriasis and rheumatologic disorders, s” View full resource at skinandallergynews.com
Most Recently Shared on June 10, 2011 at 7:21 pm By:
Skin & Allergy News Health News
Rituximab Deemed Useful for Certain Lupus Subgroups http://tinyurl.com/6ena54w
Investigational study data of REVLIMID with rituximab or rituximab-containing regimen in CLL patients presented at ASH
news-medical.net — “Celgene International Sàrl announced that clinical data from two investigational studies evaluating the use of REVLIMID (lenalidomide) either with rituximab or following a rituximab-containing regimen in patients with chronic lymphocytic leukaemia were presented at the 52nd American Society of Hematology annual meeting.” View full resource at news-medical.net
Most Recently Shared on December 6, 2010 at 9:31 am By:
Stroke News: Investigational study data of REVLIMID with rituximab or rituximab-containing regimen in CLL pati... http://twurl.nl/48ck82
Rituximab May Be Useful in Refractory Lupus (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- Rituximab appears to be both effective and safe for patients with refractory systemic lupus erythematosus an open, observational study based on physician-reported outcomes suggested.” View full resource at qualitypointtech.net
Most Recently Shared on August 6, 2010 at 3:39 pm By:
Rituximab May Be Useful in Refractory Lupus (CME/CE): (MedPage Today) -- Rituximab appears to be both effective an... http://bit.ly/aD4w7K
Statin Use in RA Patients on Rituximab May Limit Treatment Effect : Hospitalist News
ehospitalistnews.com — “Statin Use in RA Patients on Rituximab May Limit Treatment Effect : Hospitalist News” View full resource at ehospitalistnews.com
Most Recently Shared on October 28, 2010 at 8:16 pm By:
Bob Finn - Medical News Net Health News
#Statin Use in Rheumatoid #Arthritis Patients on Rituximab May Limit Treatment Effect. By Sharon Worcester for @HspNews http://bit.ly/aWd4xp
Medical News: BSR: Rituximab Helps RA in Real-World Use - in Meeting Coverage, BSR from MedPage Today
medpagetoday.com — “BRIGHTON, England -- Treatment with rituximab (Rituxan) in real-world clinical settings was effective for many patients with rheumatoid arthritis, even those who had no benefit from other biologic dru” View full resource at medpagetoday.com
Most Recently Shared on April 13, 2011 at 5:55 pm By:
BSR: Rituximab Helps RA in Real-World Use (CME/CE) http://bit.ly/gQp0Ks
Rituximab Approved as Lymphoma Maintenance - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- The FDA has approved use of rituximab (Rituxan) as maintenance therapy for advanced follicular lymphoma in patients with an initial response to induction therapy with the drug plus chemotherapy, its manufacturers said.” View full resource at qualitypointtech.net
Most Recently Shared on January 29, 2011 at 1:47 pm By:
Rituximab Approved as Lymphoma Maintenance: (MedPage Today) -- The FDA has approved use of rituximab (Rituxan) as ... http://bit.ly/e9Ajrq
Rituxan (Rituximab) for Rheumatoid Arthritis and Non-Hodgkins Lymphoma
rituxan.com — “Rituxan (Rituximab) is a unique therapy that works by selectively depleting CD20+ B-cells. B-cells, and their role in cancer and autoimmune diseases, have been an area of intensive research by scientists around the world, and at Genentech and Biogen Idec. Rituxan affects your immune system by selectively targeting CD20+ B-cells shown to play an important role in non-Hodgkin's lymphoma and rheumatoid arthritis.” View full resource at rituxan.com
Most Recently Shared on November 11, 2009 at 3:21 am By:
Rituxan generally indicated for RA when when the use of 1+TNF antagonist drug response is inadequate http://www.rituxan.com/
Rituximab Promotes Long-Term Response for Patients with Immune Destruction of Platelets
newswise.com — “A new analysis concludes that rituximab, a drug commonly used to treat blood cancers, leads to treatment responses lasting at least five years in approximately one quarter of patients with low platelet counts and a risk of bleeding due to chronic immune thrombocytopenic purpura (ITP). In study results published online today in Blood, the Journal of the American Society of Hematology (ASH), investigators at Weill Cornell Medical College provide the very first long-term outcome data for patients w” View full resource at newswise.com
Most Recently Shared on May 7, 2012 at 4:44 pm By:
#health news: Rituximab Promotes Long-Term Response for Patients with Immune Destruction of Platelets http://t.co/ebFOkm4e
NICE Recommends MabThera® (Rituximab) As First-Line Maintenance Treatment For Follicular Lymphoma
medicalnewstoday.com — “The National Institute for Health and Clinical Excellence (NICE) today issued a positive Final Appraisal Determination (FAD), recommending extended use of the antibody MabThera® (rituximab) as” View full resource at medicalnewstoday.com
Most Recently Shared on May 23, 2011 at 11:06 pm By:
NICE Recommends MabThera® (Rituximab) As First-Line Maintenance Treatment For Follicular Lymphoma http://mnt.to/3WcM #lymphoma #leukemia
Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma - Full Text View - ClinicalTrials.gov
clinicaltrials.gov — “Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma - Full Text View - ClinicalTrials.gov” View full resource at clinicaltrials.gov
Most Recently Shared on December 1, 2009 at 4:27 pm By:
Multi-center US Clinical Trial, High-Dose combo chemo + Rituxan for HIV-related Burkitt's Lymphoma http://bit.ly/6mpxyO
Combination Chemotherapy and Rituximab in Treating Patients With Primary Mediastinal Diffuse Large B-Cell Lymphoma - Full Text View - ClinicalTrials.gov
clinicaltrials.gov — “Combination Chemotherapy and Rituximab in Treating Patients With Primary Mediastinal Diffuse Large B-Cell Lymphoma - Full Text View - ClinicalTrials.gov” View full resource at clinicaltrials.gov
Most Recently Shared on September 14, 2009 at 1:04 pm By:
UK Clinical Trial for Mediastinal B-Cell Lymphoma: http://bit.ly/18gcjD
Role of Intrathecal Rituximab and Trastuzumab in the Management of Leptomeningeal Carcinomatosis (October) -- Perissinotti and Reeves, 10.1345/aph.1P197 -- The Annals of Pharmacotherapy
theannals.com — “Role of Intrathecal Rituximab and Trastuzumab in the Management of Leptomeningeal Carcinomatosis (October) -- Perissinotti and Reeves, 10.1345/aph.1P197 -- The Annals of Pharmacotherapy” View full resource at theannals.com
Most Recently Shared on September 1, 2010 at 2:16 am By:
Role of Intrathecal Rituximab and Trastuzumab in the Management of Leptomeningeal Carcinomatosis (October): ... http://bit.ly/cKB1wf
Rituximab in the Treatment of Bullous Systemic Lup... [J Clin Rheumatol. 2011] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on April 3, 2011 at 3:22 pm By:
Lupus Doctor Doctor, Internist, Rheumatologist, and Physician
Another example of off label use of rituximab helping lupus:refractory with atypical manifestion of skin diseases http://1.usa.gov/fCWv1P
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
medical_tweets
-
Drugs and Devices OW
Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.
-
Skin & Allergy News
The leading independent newspaper for medical, surgical, and aesthetic dermatology.
Advertisement
